Work

Phase 2 Multicenter Trial of Tagraxofusp in Combination with Venetoclax and Azacitidine in Adults with Previously Untreated CD123+ Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-193593

Authors: Naval Daver, Naveen Pemmaraju, Mikkael A. Sekeres, Amir T. Fathi, Andrew A. Lane, Anna Compagnoni, Ira Gupta, Alessandra Tosolini, Jessica Garzon, Hagop M. Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, University of Miami, Sylvester Comprehensive Cancer Center, Massachusetts General Hospital, Dana-Farber Cancer Institute, Menarini Group (Italy)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405034675

Cites:

Cited by: 1

Related to: 10